When measuring the value of new medicines, some countries rely on an outdated and incomplete methodology that understates the true value of innovative treatments. Setting prices in the U.S. based on these artificially low estimates of value would reduce investment in biomedical R&D and yield fewer novel medicines that address critical unmet needs of patients.

Medicines help us feel better, but there are so many other things that make medicines valuable. Learn about the many benefits of medicines and the ways that insurers overlook their value to all of us.